After years of development, third-generation expectorant ambroxol has become the most common drug in the clinical treatment of respiratory diseases. The chemical constituent of ambroxol is ambroxol hydrochloride, an active metabolite of Bromhexine. In 1981, ambroxol (trade name: Mucosolvan) developed by the German company Boehringer Ingelheim was launched. Compared with the first and second generations of expectorants, ambroxol excels in dissolving mucus. In 1994, Boehringer Ingelheim’s ambroxol entered China. Following that, the generic drugs by Chinese companies also came onto the market.
According to this market research, ambroxol has been growing rapidly since it entered China. From 2005 to 2014, its annual sales value increased from less than CNY 200 million to CNY 1.26 billion, representing a CAGR of 20.9%. From 2015 to 2019, the sales revenue of ambroxol declined in China. By sales value, Boehringer Ingelheim takes up a market share of about 43.5% in the year 2019. The rest of the market share is captured by Chinese companies, among of which are the top market players such as Changzhou Siyao Pharmaceuticals Co., Ltd., Shenyang Xinma Pharmaceutical Co., Ltd., TIPR Pharmaceutical Responsible Co., Ltd. and Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. Ambroxol is sold in China in the dosage forms of injections, solutions, syrups, granules, tablets, and capsules. Injections dominate the market.
Due to the outbreak of COVID-19 in 2020, the ability of Chinese hospitals to receive patients has declined. The decrease in the number of people seeking medical care makes China's sales and sales of ambroxol show a downward trend in 2020. It is expected that the sales of ambroxol in China in 2020 will drop.
According to the analyst, in 2021-2024, the Chinese ambroxol market will gradually recover. It is estimated that the sales of ambroxol in China will reach CNY929.41 million in 2024, and the CAGR will reach 6.0% in 2020-2024. It is estimated that the sales volume of ambroxol in China will reach 220.62 million in 2024, and the CAGR will reach 7.5% in 2020-2024.
Topics Covered:
- The situation of respiratory diseases in China
- Sales value and volume of China's ambroxol 2015-2019
- Competitive landscape of China's ambroxol market
- Prices of ambroxol in China
- Prices of ambroxol in China by regions and manufacturers
- Analysis of factors affecting the development of China's ambroxol market
- Prospects of China's ambroxol market from 2020 to 2024
Table of Contents
Companies Mentioned
- Boehringer Ingelheim (Mucosolvan)
- Changzhou Siyao Pharmaceuticals Co., Ltd. (Lansu)
- Hainan Weikang Pharmaceutical (Qianshan) Co., Ltd. (Nuoke)
- Shenyang Xinma Pharmaceutical Co., Ltd. (Kaishun)
- TIPR Pharmaceutical Responsible Co., Ltd. (Yinuoshu)
Methodology
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.
LOADING...